| Announce Date | 11/06/2025 |
| EPS Normalized Actual | $0.99 (Beat by $0.04) |
| EPS GAAP Actual | $0.99 (Beat by $0.04) |
| Revenue Actual | $0.20226B |
| Revenue Surprise | Beat by $202.26M |
| Announce Date | 12/31/1969 (Pre-Market) |
| EPS Normalized Estimate | $ |
| EPS GAAP Estimate | $ |
| Revenue Estimate | $0B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2027 | 5.82 | 15.34 | 5.7537 | 5.91891 | 1 |
| Dec 2026 | 0 | INF | 0 | 0 | 0 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ2 2025 (Jun 2025) | 0.8403 | 0.8403 | 0.20226B | 2.6% | 202.26M |
| FQ1 2025 (Mar 2025) | 0.71 | 0.71 | 0.194114B | 1.68% | 194.11M |
| FQ4 2024 (Dec 2024) | 0.46 | 0.46 | 0.197292B | 2.57% | 197.29M |
| FQ3 2024 (Sep 2024) | 0.69 | 0.69 | 0.201412B | 7% | 201.41M |
| FQ2 2024 (Jun 2024) | 0.52 | 0.52 | 0.197B | 8.02% | 197M |
| FQ1 2024 (Mar 2024) | 0.47 | 0.47 | 0.190847B | 100% | 190.85M |
| FQ4 2023 (Dec 2023) | 0.35 | 0.35 | 0.192231B | 2.93% | 192.23M |
| FQ3 2023 (Jul 2023) | 0.18 | 0.18 | 0.18732B | 100% | 187.32M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 1.36 | -- | 1.35201 | 1.36777 | 1 |
| FQ3 2027 (Sep 2027) | 1.3 | -- | 1.29236 | 1.30743 | 1 |
| FQ2 2027 (Jun 2027) | 1.16 | -- | 1.15318 | 1.16663 | 1 |
| FQ1 2027 (Mar 2027) | 1.18 | -- | 1.17307 | 1.18674 | 1 |
| FQ4 2026 (Dec 2026) | 0 | -- | 0 | 0 | 0 |
| FQ3 2026 (Sep 2026) | 0 | -- | 0 | 0 | 0 |
| FQ2 2026 (Jun 2026) | 0 | -INF | 0 | 0 | 0 |
| FQ1 2026 (Mar 2026) | 0.905 | 21.55 | 0.905 | 0.905 | 1 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 0.25B | -- | 0.24B | 0.25B | 1 |
| FQ3 2027 (Sep 2027) | 0.24B | -- | 0.24B | 0.24B | 1 |
| FQ2 2027 (Jun 2027) | 0.23B | -- | 0.23B | 0.23B | 1 |
| FQ1 2027 (Mar 2027) | 0.23B | -- | 0.23B | 0.23B | 1 |
| FQ4 2026 (Dec 2026) | 0.22B | -- | 0.22B | 0.22B | 1 |
| FQ3 2026 (Sep 2026) | 0.22B | -- | 0.22B | 0.22B | 1 |
| FQ2 2026 (Jun 2026) | 0.21B | 5.56 | 0.21B | 0.22B | 1 |
| FQ1 2026 (Mar 2026) | 0.21B | 6.02 | 0.21B | 0.21B | 2 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
8
EPS # of Misses
0
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ2 2025 (Jun 2025) | 0.8403 | 0.8403 | 100% | |
| FQ1 2025 (Mar 2025) | 0.71 | 0.71 | 100% | |
| FQ4 2024 (Dec 2024) | 0.46 | 0.46 | 100% | |
| FQ3 2024 (Sep 2024) | 0.69 | 0.69 | 100% | |
| FQ2 2024 (Jun 2024) | 0.52 | 0.52 | 100% | |
| FQ1 2024 (Mar 2024) | 0.47 | 0.47 | 100% | |
| FQ4 2023 (Dec 2023) | 0.35 | 0.35 | 100% | |
| FQ3 2023 (Jul 2023) | 0.18 | 0.18 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ2 2025 (Jun 2025) | $0B | $0.2B | $202.26M | 100% |
| FQ1 2025 (Mar 2025) | $0B | $0.19B | $194.11M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $0.2B | $197.29M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $0.2B | $201.41M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $0.2B | $197M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $0.19B | $190.85M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $0.19B | $192.23M | 100% |
| FQ3 2023 (Jul 2023) | $0B | $0.19B | $187.32M | 100% |